Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept

BACKGROUND: Two randomized phase III trials (EORTC55971 and CHORUS) showed similar progression-free and overall survival in primary or interval debulking surgery in ovarian cancer, however both studies had limitations with lower rate of complete resection and lack of surgical qualifications for part...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:J Gynecol Oncol
Main Authors: Jiang, Rong, Zhu, Jianqing, Kim, Jae-Weon, Liu, Jihong, Kato, Kazuyoshi, Kim, Hee-Seung, Zhang, Yuqin, Zhang, Ping, Zhu, Tao, Aoki, Daisuke, Yu, Aijun, Chen, Xiaojun, Wang, Xipeng, Zhu, Ding, Zhang, Wei, Jia, Huixun, Shi, Tingyan, Gao, Wen, Yin, Sheng, Feng, Yanling, Xiang, Libing, Okamoto, Aikou, Zang, Rongyu
פורמט: Artigo
שפה:Inglês
יצא לאור: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2020
נושאים:
Clinical Trial Protocol
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7440987/
https://ncbi.nlm.nih.gov/pubmed/32808504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2020.31.e86
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים